Dashboard
Manage Tickers

OB OneBeacon Insurance Group, ...

NYSE www.onebeacon.com


$ 0.00 (0 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 18.09
-- x --
-- x --
-- - --
$ 12.97 - $ 18.22
280,990
na
1.71B
$ 0.75
$ 6.57
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-04-2017 06-30-2017 10-Q
2 05-02-2017 03-31-2017 10-Q
3 02-27-2017 12-31-2016 10-K
4 11-02-2016 09-30-2016 10-Q
5 08-03-2016 06-30-2016 10-Q
6 05-02-2016 03-31-2016 10-Q
7 02-26-2016 12-31-2015 10-K
8 11-02-2015 09-30-2015 10-Q
9 08-03-2015 06-30-2015 10-Q
10 05-04-2015 03-31-2015 10-Q
11 02-27-2015 12-31-2014 10-K
12 10-29-2014 09-30-2014 10-Q
13 07-29-2014 06-30-2014 10-Q
14 04-28-2014 03-31-2014 10-Q
15 02-28-2014 12-31-2013 10-K
16 10-28-2013 09-30-2013 10-Q
17 07-30-2013 06-30-2013 10-Q
18 04-29-2013 03-31-2013 10-Q
19 02-28-2013 12-31-2012 10-K
20 10-30-2012 09-30-2012 10-Q
21 07-27-2012 06-30-2012 10-Q
22 04-27-2012 03-31-2012 10-Q
23 02-28-2012 12-31-2011 10-K
24 10-28-2011 09-30-2011 10-Q
25 07-29-2011 06-30-2011 10-Q
26 04-29-2011 03-31-2011 10-Q
27 02-28-2011 12-31-2010 10-K
28 10-29-2010 09-30-2010 10-Q
29 07-30-2010 06-30-2010 10-Q
30 04-29-2010 03-31-2010 10-Q
31 02-26-2010 12-31-2009 10-K
32 10-30-2009 09-30-2009 10-Q
33 07-31-2009 06-30-2009 10-Q
34 05-01-2009 03-31-2009 10-Q
35 02-27-2009 12-31-2008 10-K
36 10-31-2008 09-30-2008 10-Q
37 08-01-2008 06-30-2008 10-Q
38 05-02-2008 03-31-2008 10-Q
39 02-29-2008 12-31-2007 10-K
40 11-05-2007 09-30-2007 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

outbrain-completes-name-change-to-teads-holding-co-to-begin-trading-under-new-nasdaq-symbol-tead-effective-june-10
Outbrain Completes Name Change to Teads Ho...
06/09/2025 11:19:19

Outbrain Inc. (NASDAQ:OB), which is operating under the new Teads brand following Outbrain's acquisition of Teads in Februa...

top-3-tech-and-telecom-stocks-that-may-rocket-higher-this-month
Top 3 Tech And Telecom Stocks That May Roc...
05/19/2025 10:35:43

citigroup-maintains-neutral-on-outbrain-lowers-price-target-to-39
Citigroup Maintains Neutral on Outbrain, L...
05/12/2025 18:36:28

Citigroup analyst Ygal Arounian maintains Outbrain (NASDAQ:OB) with a Neutral and lowers the price target from $4 to $3.9.

outbrain-q1-adj-eps-020-misses-010-estimate-sales-28636m-beat-27975m-estimate
Outbrain Q1 Adj. EPS $(0.20) Misses $(0.10...
05/09/2025 10:33:25

Outbrain (NASDAQ:OB) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.10) by 1...

Core News & Articles
Earnings Scheduled For May 9, 2025
05/09/2025 08:32:15

earnings-outlook-for-outbrain
Earnings Outlook For Outbrain
05/08/2025 17:01:48

citigroup-maintains-neutral-on-outbrain-lowers-price-target-to-4
Citigroup Maintains Neutral on Outbrain, L...
04/25/2025 14:03:45

Citigroup analyst Ygal Arounian maintains Outbrain (NASDAQ:OB) with a Neutral and lowers the price target from $5.9 to $4.

a-glimpse-into-the-expert-outlook-on-outbrain-through-7-analysts
A Glimpse Into The Expert Outlook On Outbr...
03/21/2025 22:00:20

needham-reiterates-buy-on-outbrain-maintains-9-price-target
Needham Reiterates Buy on Outbrain, Mainta...
03/21/2025 13:00:42

Needham analyst Laura Martin reiterates Outbrain (NASDAQ:OB) with a Buy and maintains $9 price target.

citigroup-maintains-neutral-on-outbrain-lowers-price-target-to-59
Citigroup Maintains Neutral on Outbrain, L...
02/28/2025 19:09:56

Citigroup analyst Ygal Arounian maintains Outbrain (NASDAQ:OB) with a Neutral and lowers the price target from $7.8 to $5.9.

demystifying-outbrain-insights-from-6-analyst-reviews
Demystifying Outbrain: Insights From 6 Ana...
02/28/2025 14:00:41

needham-reiterates-buy-on-outbrain-maintains-9-price-target
Needham Reiterates Buy on Outbrain, Mainta...
02/28/2025 11:57:38

Needham analyst Laura Martin reiterates Outbrain (NASDAQ:OB) with a Buy and maintains $9 price target.

outbrain-q4-adj-eps-007-misses-008-estimate-sales-23459m-miss-24903m-estimate
Outbrain Q4 Adj EPS $0.07 Misses $0.08 Est...
02/27/2025 11:33:57

Outbrain (NASDAQ:OB) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.08 by 12....

earnings-scheduled-for-february-27-2025
Earnings Scheduled For February 27, 2025
02/27/2025 08:32:34

jmp-securities-maintains-market-outperform-on-outbrain-raises-price-target-to-10
JMP Securities Maintains Market Outperform...
02/04/2025 18:14:55

JMP Securities analyst Ronald Josey maintains Outbrain (NASDAQ:OB) with a Market Outperform and raises the price target from...

deal-dispatch-sage-and-silvus-are-up-for-sale-mrbeast-secures-20b-for-tiktok
Deal Dispatch: Sage And Silvus Are Up For ...
01/31/2025 19:20:27

Sage Therapeutics rejects Biogen deal offer; Silvus Technologies considers sale/IPO; Allakos downsizes; MrBeast bids on TikTok.

Core News & Articles
UK's Has Cleared The Anticipated Acquisiti...
01/31/2025 11:19:47

https://www.gov.uk/cma-cases/outbrain-inc-slash-teads-sa-merger-inquiry

jmp-securities-reiterates-market-outperform-on-outbrain-maintains-7-price-target
JMP Securities Reiterates Market Outperfor...
01/27/2025 17:39:26

JMP Securities analyst Greg Miller reiterates Outbrain (NASDAQ:OB) with a Market Outperform and maintains $7 price target.

beyond-the-numbers-4-analysts-discuss-outbrain-stock
Beyond The Numbers: 4 Analysts Discuss Out...
01/21/2025 14:00:41

needham-reiterates-buy-on-outbrain-maintains-9-price-target
Needham Reiterates Buy on Outbrain, Mainta...
01/21/2025 12:20:23

Needham analyst Laura Martin reiterates Outbrain (NASDAQ:OB) with a Buy and maintains $9 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION